Find a company
| Project | Home based treatment for Diabetic Retinopathy and Age-related Macular Degeneration |
|---|---|
| Description |
The Phase 3 project has been the catalyst for Noctura 400 (non-invasive, home based treatment for Diabetic Retinopathy) evaluation within the NHS. It has also initiated complimentary evaluation for early stage disease intervention in a primary care Optometry setting. Noctura 400 exposure has been increased as a result and as such has stimulated significant adoption interest from both patient groups and eye care professionals. |
| Funding | £ 1,215,132 |
| Competition | Competitions 1- 4 |
| Competition Date | September 2013 |
| Health Innovation Network Partner | Health Innovation North East and North Cumbria |
| Website | http://www.polyphotonix.com/ |